My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 154

    1.

    Demonstration of a hyperglycemia-driven pathogenic abnormality of copper homeostasis in diabetes and its reversibility by selective chelation: quantitative comparisons between the biology of copper and eight other nutritionally essential elements in normal and diabetic individuals.

    Cooper GJ, Chan YK, Dissanayake AM, Leahy FE, Keogh GF, Frampton CM, Gamble GD, Brunton DH, Baker JR, Poppitt SD.

    Diabetes. 2005 May;54(5):1468-76.PMID: 15855335 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Regeneration of the heart in diabetes by selective copper chelation.

    Cooper GJ, Phillips AR, Choong SY, Leonard BL, Crossman DJ, Brunton DH, Saafi L, Dissanayake AM, Cowan BR, Young AA, Occleshaw CJ, Chan YK, Leahy FE, Keogh GF, Gamble GD, Allen GR, Pope AJ, Boyd PD, Poppitt SD, Borg TK, Doughty RN, Baker JR.

    Diabetes. 2004 Sep;53(9):2501-8.PMID: 15331567 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    A copper(II)-selective chelator ameliorates left-ventricular hypertrophy in type 2 diabetic patients: a randomised placebo-controlled study.

    Cooper GJ, Young AA, Gamble GD, Occleshaw CJ, Dissanayake AM, Cowan BR, Brunton DH, Baker JR, Phillips AR, Frampton CM, Poppitt SD, Doughty RN.

    Diabetologia. 2009 Apr;52(4):715-22. Epub 2009 Jan 27.PMID: 19172243 [PubMed - indexed for MEDLINE]Related articles

    4.

    A copper(II)-selective chelator ameliorates diabetes-evoked renal fibrosis and albuminuria, and suppresses pathogenic TGF-beta activation in the kidneys of rats used as a model of diabetes.

    Gong D, Lu J, Chen X, Reddy S, Crossman DJ, Glyn-Jones S, Choong YS, Kennedy J, Barry B, Zhang S, Chan YK, Ruggiero K, Phillips AR, Cooper GJ.

    Diabetologia. 2008 Sep;51(9):1741-51. Epub 2008 Jul 18.PMID: 18636238 [PubMed - indexed for MEDLINE]Related articles

    5.

    Copper, zinc, manganese, and magnesium status and complications of diabetes mellitus.

    Walter RM Jr, Uriu-Hare JY, Olin KL, Oster MH, Anawalt BD, Critchfield JW, Keen CL.

    Diabetes Care. 1991 Nov;14(11):1050-6.PMID: 1797486 [PubMed - indexed for MEDLINE]Related articles

    6.

    Reduction of activity, but no decrease in concentration, of erythrocyte Cu,Zn-superoxide dismutase by hyperglycaemia in diabetic patients.

    Kotake M, Shinohara R, Kato K, Hayakawa N, Hayashi R, Uchimura K, Makino M, Nagata M, Kakizawa H, Nakagawa H, Nagasaka A, Itoh M.

    Diabet Med. 1998 Aug;15(8):668-71.PMID: 9702470 [PubMed - indexed for MEDLINE]Related articles

    7.

    Serum sialic acid levels and selected mineral status in patients with type 2 diabetes mellitus.

    Ekin S, Mert N, Gunduz H, Meral I.

    Biol Trace Elem Res. 2003 Sep;94(3):193-201.PMID: 12972687 [PubMed - indexed for MEDLINE]Related articles

    8.

    The effects of impaired trace element status on polymorphonuclear leukocyte activation in the development of vascular complications in type 2 diabetes mellitus.

    Karahan SC, Değer O, Orem A, Uçar F, Erem C, Alver A, Onder E.

    Clin Chem Lab Med. 2001 Feb;39(2):109-15.PMID: 11341743 [PubMed - indexed for MEDLINE]Related articles

    9.

    Copper, chromium, manganese, iron, nickel, and zinc levels in biological samples of diabetes mellitus patients.

    Kazi TG, Afridi HI, Kazi N, Jamali MK, Arain MB, Jalbani N, Kandhro GA.

    Biol Trace Elem Res. 2008 Apr;122(1):1-18. Epub 2008 Jan 11.PMID: 18193174 [PubMed - indexed for MEDLINE]Related articles

    10.

    Molecular changes evoked by triethylenetetramine treatment in the extracellular matrix of the heart and aorta in diabetic rats.

    Gong D, Lu J, Chen X, Choong SY, Zhang S, Chan YK, Glyn-Jones S, Gamble GD, Phillips AR, Cooper GJ.

    Mol Pharmacol. 2006 Dec;70(6):2045-51. Epub 2006 Sep 14.PMID: 16973718 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Serum extracellular superoxide dismutase in patients with type 2 diabetes: relationship to the development of micro- and macrovascular complications.

    Kimura F, Hasegawa G, Obayashi H, Adachi T, Hara H, Ohta M, Fukui M, Kitagawa Y, Park H, Nakamura N, Nakano K, Yoshikawa T.

    Diabetes Care. 2003 Apr;26(4):1246-50.PMID: 12663605 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Altered metabolism of copper, zinc, and magnesium is associated with increased levels of glycated hemoglobin in patients with diabetes mellitus.

    Viktorínová A, Toserová E, Krizko M, Duracková Z.

    Metabolism. 2009 Oct;58(10):1477-82. Epub 2009 Jul 9.PMID: 19592053 [PubMed - indexed for MEDLINE]Related articles

    13.

    Antioxidant and oxidative stress status in type 2 diabetes and diabetic foot ulcer.

    Bolajoko EB, Mossanda KS, Adeniyi F, Akinosun O, Fasanmade A, Moropane M.

    S Afr Med J. 2008 Aug;98(8):614-7.PMID: 18928040 [PubMed - indexed for MEDLINE]Related articles

    14.

    Urinary excretion of chromium, copper, and manganese in diabetes mellitus and associated disorders.

    el-Yazigi A, Hannan N, Raines DA.

    Diabetes Res. 1991 Nov;18(3):129-34.PMID: 1841823 [PubMed - indexed for MEDLINE]Related articles

    15.

    Hyperglycaemia increases dipeptidyl peptidase IV activity in diabetes mellitus.

    Mannucci E, Pala L, Ciani S, Bardini G, Pezzatini A, Sposato I, Cremasco F, Ognibene A, Rotella CM.

    Diabetologia. 2005 Jun;48(6):1168-72. Epub 2005 Apr 29.PMID: 15864535 [PubMed - indexed for MEDLINE]Related articles

    16.

    Concentrations of seven trace elements in different hematological matrices in patients with type 2 diabetes as compared to healthy controls.

    Ekmekcioglu C, Prohaska C, Pomazal K, Steffan I, Schernthaner G, Marktl W.

    Biol Trace Elem Res. 2001 Mar;79(3):205-19.PMID: 11354346 [PubMed - indexed for MEDLINE]Related articles

    17.

    Triethylenetetramine and metabolites: levels in relation to copper and zinc excretion in urine of healthy volunteers and type 2 diabetic patients.

    Lu J, Chan YK, Gamble GD, Poppitt SD, Othman AA, Cooper GJ.

    Drug Metab Dispos. 2007 Feb;35(2):221-7. Epub 2006 Nov 15.PMID: 17108057 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Angiotensin type-1 receptor blockade with losartan increases insulin sensitivity and improves glucose homeostasis in subjects with type 2 diabetes and nephropathy.

    Jin HM, Pan Y.

    Nephrol Dial Transplant. 2007 Jul;22(7):1943-9. Epub 2007 Feb 17.PMID: 17308317 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Diabetes and dietary copper alter 67Cu metabolism and oxidant defense in the rat.

    Uriu-Adams JY, Rucker RB, Commisso JF, Keen CL.

    J Nutr Biochem. 2005 May;16(5):312-20.PMID: 15866232 [PubMed - indexed for MEDLINE]Related articles

    20.

    The role of zinc, copper and iron in the pathogenesis of diabetes and diabetic complications: therapeutic effects by chelators.

    Zheng Y, Li XK, Wang Y, Cai L.

    Hemoglobin. 2008;32(1-2):135-45. Review.PMID: 18274991 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity